- Nonalcoholic steatohepatitis2003 | First Faculty of Medicine
- Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis2023 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis2021 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Therapy of nonalcoholic steatohepatitis (NASH)2016 | Publication without faculty affiliation
- Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir2016 | Faculty of Medicine in Hradec Králové
- Nonalcoholic steatohepatitis (NASH) +12007 | Faculty of Medicine in Hradec Králové
- Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis2020 | Publication without faculty affiliation
- Perinatal Nutritional Reprogramming of the Epigenome Promotes Subsequent Development of Nonalcoholic Steatohepatitis2018 | Publication without faculty affiliation
- mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis2022 | First Faculty of Medicine
- Metabolomic-Based Noninvasive Serum Test to Diagnose Nonalcoholic Steatohepatitis: Results From Discovery and Validation Cohorts2018 | First Faculty of Medicine
- Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis2021 | Faculty of Medicine in Hradec Králové
- Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis2013 | Faculty of Medicine in Hradec Králové
- Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver2020 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Moderate wine drinking causes cirrhosis, but it improves liver function2015 | Publication without faculty affiliation
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASHPublication without faculty affiliation
- Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation2018 | Faculty of Medicine in Hradec Králové
- Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles2022 | First Faculty of Medicine
- Drug-Metabolizing and Antioxidant Enzymes in Monosodium L-Glutamate Obese Mice2015 | Faculty of Pharmacy in Hradec Králové
- Steatosis and steatohepatitis in diabetic patient2011 | Faculty of Medicine in Hradec Králové
- Osteopontin as a Biomarker in Liver Disease2016 | First Faculty of Medicine
- Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease2021 | Faculty of Medicine in Pilsen
- Iron oxide nanoparticles trigger endoplasmic reticulum damage in steatotic hepatic cells2023 | Central Library of Charles University, Faculty of Mathematics and Physics
- Western Diet Decreases the Liver Mitochondrial Oxidative Flux of Succinate: Insight from a Murine NAFLD Model2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study2014 | First Faculty of Medicine
- Familial Adenomatous Polyposis and Desmoid Tumor Treated With Multivisceral Transplantation and Kidney Autotransplantation: Case Report and Literature Review2019 | Central Library of Charles University, Second Faculty of Medicine
- Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients2019 | First Faculty of Medicine, Central Library of Charles University